Cargando…
The Expression and Therapeutic Potential of Checkpoint Kinase 2 in Laryngeal Squamous Cell Carcinoma
INTRODUCTION: Laryngeal squamous cell carcinoma (LSCC) is the most common histological subtype of laryngeal cancer. The involved molecular mechanisms and suitable therapeutic targets for LSCC still need to be further investigated. Checkpoint kinase 2 (CHK2) participates in several cellular physiolog...
Autores principales: | Tian, Ying, Wang, Yan, Xu, Shan, Guan, Chao, Zhang, Qingfu, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351626/ https://www.ncbi.nlm.nih.gov/pubmed/32753843 http://dx.doi.org/10.2147/DDDT.S245267 |
Ejemplares similares
-
ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022) -
Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma
por: GUAN, GUO-FANG, et al.
Publicado: (2015) -
Galectin-8 Expression in Laryngeal Squamous Cell Carcinoma
por: Dong, Geun Woo, et al.
Publicado: (2009) -
Gene expression analysis of laryngeal squamous cell carcinoma
por: Plaça, Jessica Rodrigues, et al.
Publicado: (2015) -
Significance of Parafibromin Expression in Laryngeal Squamous Cell Carcinomas
por: Cho, Inju, et al.
Publicado: (2016)